Sign up to save your podcasts
Or
Share E161 - Comparative Effectiveness of Intravenous Ketamine and Intranasal Esketamine in Real-World Setting Among Patients with Treatment Refractory Depression
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E161 - Comparative Effectiveness of Intravenous Ketamine and Intranasal Esketamine in Real-World Setting Among Patients with Treatment Refractory Depression
What are some of the major differences between intravenous or IV ketamine and intranasal esketamine? How are you building on these research findings and what associated avenues have been explored?
In this episode, we interview the poster winner from last year's NEI Congress, Dr. Balwinder Singh on his research comparing intravenous ketamine and intranasal esketamine. The study, conducted at Mayo Clinic rendered interesting findings that may be important for clinicians.
Dr. Balwinder Singh is a Consultant and Assistant professor in the Department of Psychiatry at Mayo Clinic in Rochester, Minnesota. He is a psychiatrist specializing in mood disorders, and his research is focused on novel treatments for treatment-resistant depression and identifying biomarkers for ketamine response. He is also involved in the ketamine and esketamine clinic practice at the Mayo Clinic Depression Center.
This is one of the first studies to highlight a faster response to intravenous ketamine as compared to intranasal esketamine in an observational study.
Title: Comparative Effectiveness of Intravenous Ketamine and Intranasal Esketamine in Clinical Practice Among Patients With Treatment-Refractory Depression: An Observational Study Byline: Balwinder Singh; Simon Kung; Vanessa Pazdernik; Kathryn M. Schak; Jennifer Geske; Phillip J. Schulte; Mark A. Frye; Jennifer L. Vande Voort Citation: J Clin Psychiatry 2023;84(2):22m14548 DOI: https://doi.org/10.4088/JCP.22m14548 URL: Comparative Effectiveness of Intravenous Ketamine and Intranasal Esketamine in Clinical Practice Among Patients With Treatment-Refractory Depression: An Observational Study | Psychiatrist.com
View all episodes
By Neuroscience Education Institute
4.5
128128 ratings
What are some of the major differences between intravenous or IV ketamine and intranasal esketamine? How are you building on these research findings and what associated avenues have been explored?
In this episode, we interview the poster winner from last year's NEI Congress, Dr. Balwinder Singh on his research comparing intravenous ketamine and intranasal esketamine. The study, conducted at Mayo Clinic rendered interesting findings that may be important for clinicians.
Dr. Balwinder Singh is a Consultant and Assistant professor in the Department of Psychiatry at Mayo Clinic in Rochester, Minnesota. He is a psychiatrist specializing in mood disorders, and his research is focused on novel treatments for treatment-resistant depression and identifying biomarkers for ketamine response. He is also involved in the ketamine and esketamine clinic practice at the Mayo Clinic Depression Center.
This is one of the first studies to highlight a faster response to intravenous ketamine as compared to intranasal esketamine in an observational study.
Title: Comparative Effectiveness of Intravenous Ketamine and Intranasal Esketamine in Clinical Practice Among Patients With Treatment-Refractory Depression: An Observational Study Byline: Balwinder Singh; Simon Kung; Vanessa Pazdernik; Kathryn M. Schak; Jennifer Geske; Phillip J. Schulte; Mark A. Frye; Jennifer L. Vande Voort Citation: J Clin Psychiatry 2023;84(2):22m14548 DOI: https://doi.org/10.4088/JCP.22m14548 URL: Comparative Effectiveness of Intravenous Ketamine and Intranasal Esketamine in Clinical Practice Among Patients With Treatment-Refractory Depression: An Observational Study | Psychiatrist.com
More shows like NEI Podcast
View all
ADHD Experts Podcast
1,332 Listeners
Being Well with Forrest Hanson and Dr. Rick Hanson
2,504 Listeners
The Curbsiders Internal Medicine Podcast
3,354 Listeners
PsychEd: Educational Psychiatry Podcast
155 Listeners
Psychiatry & Psychotherapy Podcast
1,351 Listeners
Real Life Pharmacology - Pharmacology Education for Health Care Professionals
730 Listeners
Psychopharmacology and Psychiatry Updates
292 Listeners
Navigating Neuropsychology
361 Listeners
The Carlat Psychiatry Podcast
573 Listeners
Back from the Abyss: Psychiatry in Stories
470 Listeners
Psychology Unplugged
733 Listeners
Dr. Streicher’s Inside Information: Menopause, Midlife, and More
374 Listeners
The Mel Robbins Podcast
19,806 Listeners
Psychiatry Boot Camp
189 Listeners
PsychRounds: The Psychiatry Podcast
150 Listeners